Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.16
+0.31 (3.56%)
Nov 4, 2026, 11:35 AM EST - Market open
Haleon Market Cap
Haleon has a market cap or net worth of $39.85 billion as of November 4, 2026. Its market cap has decreased by 4.84% in one year.
Market Cap
39.85B
Enterprise Value
49.90B
1-Year Change
-4.84%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $39.85B, an increase of 16.72%. That is a compound annual growth rate of 3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 39.85B | -11.29% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 67.42B |
| Teva Pharmaceutical Industries | 49.05B |
| Zoetis | 32.94B |
| United Therapeutics | 25.68B |
| Viatris | 21.86B |
| Neurocrine Biosciences | 14.85B |
| Dr. Reddy's Laboratories | 11.85B |
| Elanco Animal Health | 11.52B |